Skip NavigationSkip to Content
Return Return to Search Results

Rational design of drugs that induce human immunodeficiency virus replication

  1. Author:
    Hamer, D. H.
    Bocklandt, S.
    McHugh, L.
    Chun, T. W.
    Blumberg, P. M.
    Sigano, D. M.
    Marquez, V. E.

  2. Author Address

    NCI, Biochem Lab, NIH, Bldg 37,Rm 6002,9000 Rockville Pike, Bethesda, MD 20892 USA NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA NCI, Cellular Carcinogenesis & Tumor Promot Lab, Canc Res Ctr, Bethesda, MD 20892 USA NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA NCI, Med Chem Lab, Canc Res Ctr, NIH, Frederick, MD 21702 USA Hamer DH NCI, Biochem Lab, NIH, Bldg 37,Rm 6002,9000 Rockville Pike, Bethesda, MD 20892 USA
    1. Year: 2003
  2. Journal: Journal of Virology
    1. 77
    2. 19
    3. Pages: 10227-10236
  4. Type of Article: Article
  1. Abstract:

    Drugs that induce human immunodeficiency virus type 1 (HIV-1) replication could be used in combination with highly active antiretroviral therapy (HAART) to reduce the size of the latent reservoir that is in part responsible for viral persistence. Protein kinase C (PKC) is a logical target for such drugs because it activates HIV-1 transcription through multiple mechanisms. Here we show that HIV-1 gene expression can be induced by potent synthetic analogues of the lipid second messenger diacylglycerol (DAG) synthesized on a five-member ring platform that reduces the entropy of binding relative to that of the more flexible DAG template. By varying the alkyl side chains of these synthetic DAG lactones, it was possible to maximize their potency and ability to render latently infected T cells sensitive to killing by an anti-HIV-1 immunotoxin while minimizing the side effects of CD4 and CXCR4 downregulation and tumor necrosis factor alpha upregulation. The two lead compounds, LMC03 and LMC07, regulated a series of PKC-sensitive genes involved in T-cell activation and induced viral gene expression in peripheral blood mononuclear cells from HIV-1- infected individuals. These studies demonstrate the potential for the rational design of agents that, in conjunction with HAART and HIV-specific toxins, can be used to decrease or eliminate the pool of latently infected reservoirs by forcing viral expression.

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel